Martin Jones

58PUBLICATIONS
247CO-AUTHORS
Haematological tumoursEpigenetics (incl. genome methylation and epigenomics)Molecular targetsCancer geneticsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (58)

|Oct 10, 2025
Population-wide introduction of dose-adjusted EPOCH-R in high-grade B-cell lymphoma with MYC/BCL2 rearrangements, DLBCL morphology.

Waleed Alduaij, Laurie H Sehn, Jean-Nicolas Champagne

|Jul 17, 2025
High-grade B-cell lymphoma, not otherwise specified: an LLMPP study.

Brett Collinge, Laura K Hilton, Jasper Wong

|May 08, 2025
DNA Methylation Epitypes of Burkitt Lymphoma with Distinct Molecular and Clinical Features.

Nicole Thomas, Carlos A García-Prieto, Kostiantyn Dreval

|Apr 09, 2025
Proteomics and personalized PDX models identify treatment for a progressive malignancy within an actionable timeframe.

Georgina D Barnabas, Tariq A Bhat, Verena Goebeler

|Dec 05, 2024
Rearrangements of viral and human genomes at human papillomavirus integration events and their allele-specific impacts on cancer genome regulation.

Vanessa L Porter, Michelle Ng, Kieran O'Neill

|Nov 27, 2024
Correction: Titmuss et al. Immune Activation Following Irbesartan Treatment in a Colorectal Cancer Patient: A Case Study. Int. J. Mol. Sci. 2023, 24, 5869.

E Titmuss, K Milne, M R Jones

Pageof 10

Frequent Collaborators

33 joint publications

Marco A Marra

30 joint publications

Steven Jones

11 joint publications

Pedro Farinha

10 joint publications

Ryan D Morin